Amputation Prevention in Peripheral Neuropathy: How the NeuropaCalm Care Program is Changing Lives

Peripheral neuropathy is far more than an uncomfortable condition. For millions of Americans, it represents a slow and silent march toward devastating outcomes: ulcers, infections, loss of independence, and, too often, limb amputation. According to the National Institute of Diabetes and Digestive and Kidney Diseases, about 60–70% of people with diabetes will develop some form of neuropathy over their lifetime. Among these patients, diabetic foot ulcers precede 85% of lower-limb amputations.

The statistics are sobering, but they also point to a critical opportunity: early detection and proactive therapies can dramatically reduce the risk of limb loss. That’s where the NeuropaCalm Care Program steps in.

Read More